NCT00746395View on ClinicalTrials.gov

Randomized, Placebo-controlled Trial of Lubiprostone as a Preparation for Capsule Endoscopy

PHASE4CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Inflammatory Bowel Disease
Interventions
DRUG

Lubiprostone

24 mcg oral administration

DRUG

Placebo

Oral administration

Trial Locations (1)

36693

USA Pavilion at Infirmary West, Mobile

Sponsors

Collaborators (1)

Takeda
All Listed Sponsors
collaborator

Takeda

INDUSTRY

collaborator

Sucampo Pharmaceuticals, Inc.

INDUSTRY

lead

University of South Alabama

OTHER

NCT00746395 - Randomized, Placebo-controlled Trial of Lubiprostone as a Preparation for Capsule Endoscopy | Biotech Hunter | Biotech Hunter